Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities

Metabolic and neurodegenerative disorders have a growing prevalence in Western countries. Available epidemiologic and neurobiological evidences support the existence of a pathophysiological link between these conditions. Glucagon-like peptide 1 (GLP-1), whose activity is reduced in insulin resistanc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mossello, Enrico, Ballini, Elena, Boncinelli, Marta, Monami, Matteo, Lonetto, Giuseppe, Mello, Anna Maria, Tarantini, Francesca, Baldasseroni, Samuele, Mannucci, Edoardo, Marchionni, Niccolò
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124026/
https://ncbi.nlm.nih.gov/pubmed/21747826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/281674
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares